- Home
- SVAC vs FENC Comparison
SVAC vs FENC Comparison
Compare SVAC & FENC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
N/A
N/A
Current Price
$7.82
Company Overview
Basic Information| Metric | SVAC | FENC |
|---|---|---|
| Founded | 2025 | 1996 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Blank Checks | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 312.2M | 263.3M |
| IPO Year | N/A | 2010 |
Fundamental Metrics
Financial Performance| Metric | SVAC | FENC |
|---|---|---|
| Price | $10.20 | $7.82 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $15.00 |
| AVG Volume (30 Days) | 79.8K | ★ 114.9K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 96.67 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $47,538,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $70.78 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 123.69 |
| 52 Week Low | $10.06 | $4.68 |
| 52 Week High | $12.00 | $9.92 |
Technical Indicators
Market Signals| Indicator | SVAC | FENC |
|---|---|---|
| Relative Strength Index (RSI) | 35.75 | 44.15 |
| Support Level | $10.12 | $7.40 |
| Resistance Level | $10.32 | $8.09 |
| Average True Range (ATR) | 0.10 | 0.41 |
| MACD | -0.03 | -0.12 |
| Stochastic Oscillator | 6.67 | 29.38 |
Price Performance
Historical Comparison SVAC
FENC
About SVAC Spring Valley Acquisition Corp. III Class A Ordinary Shares
Spring Valley Acquisition Corp III is a blank check company.
About FENC Fennec Pharmaceuticals Inc.
Fennec Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. Its product candidate is PEDMARK which is sodium thiosulfate in a novel formulation for the prevention of cisplatin-induced hearing loss, or ototoxicity in children. The company principally operates in the United States.